Loading company…
ID 415099985 · FY 2022–2024 · 3 years
1.2 კომპანიის ძირითად საქმიანობას წარმოადგენს: - საბითუმო ვაჭრობა ფარმაცევტული საქონლითთავისუფალ ინდუსტრიულ ზონაში 1.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|
| Net Cash from Operating Activities | 845 | 1,172 | 1,701 | +41.9% |
| Net Cash from Financing Activities | -735 | -1,246 | -1,491 | +42.5% |
| Net Change in Cash (before FX) | 111 | -74 | 210 | +37.7% |
| Effect of FX on Cash | 26 | 20 | 0 | -22.7% |
| Net Change in Cash (incl. FX) | 136 | -54 | 210 | +24.1% |
| Cash at Beginning of Year | 0 | 136 | 82 | -39.7% |
| Cash at End of Year | 136 | 82 | 292 | +46.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.